Obesity clinical trials in Georgia
46 studies for Obesity are looking for participants at sites in Georgia.
Cities in Georgia
- Atlanta26 studies
- Roswell16 studies
- Johns Creek14 studies
- South Fulton11 studies
- Sandy Springs5 studies
- Columbus4 studies
- Gainesville3 studies
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Nsc Research, Johns Creek
- North Georgia Clinical Research, Woodstock
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 9, 2026 · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351045A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Stockbridge
- Research Site, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centricity Research Columbus Georgia Multispecialty, Columbus
- Atlanta Veterans Affairs Medical Center, Decatur
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- East Coast Institute for Research, Canton
- Nsc Research, Johns Creek
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT07575399A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Clinical Research Atlanta, Stockbridge
- North Georgia Clinical Research, LLC, Woodstock
- North Georgia Internal Medicine, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07919678A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Care Access - Dalton - Clinical Trials Center by Walmart & Care Access, Dalton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Southeast Research Specialists, Douglasville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 4, 2026 · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Teak Research Consults - Dunwoody, Dunwoody
- Teak Research Consults, Lawrenceville
- The Jones Center Clinical Research, Macon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Teak Research Consults - Dunwoody, Dunwoody
- Center for Advanced Research & Education, Gainesville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Orita Clinical Research, Decatur
- North Georgia Clinical Research, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Teak Research Consults, Lawrenceville
- EBGS Clinical Research Center, Snellville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07369011A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
- Physicians Research Associates, Lawrenceville
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- North Georgia Clinical Research, Woodstock
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Stockbridge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Piedmont Heart Institute, Atlanta
- Privia Medical Group Georgia LLC, Peachtree City
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 29, 2026 · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Woodstock
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Endocrine Research Solutions /ID# 282020, Roswell
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- North Georgia Clinical Research, Woodstock
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 26, 2026 · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Atlanta
- ACCOMPLISH-2 Research Site, Columbus
- ACCOMPLISH-2 Research Site, Lawrenceville
- and 2 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT07607587The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Denali Health Atlanta, Atlanta
- Drug Studies America, Marietta
- EBGS Clinical Research, Snellville
Recruiting
Ages 22 to 65 · All sexes · Updated Oct 13, 2026 · NCT04101669AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- NeuroTrials Research, Inc., Atlanta
- Physicians Research Associates, Lawrenceville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Center for Advanced Research and Education, Gainesville
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684235A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Children's Healthcare Atlanta, Atlanta
- Columbus Research Foundation, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- and 1 more
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Sep 30, 2026 · NCT07253285AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Conquest Research, Atlanta
- Eastside Bariatric and Gen Surg, Snellville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07339423A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Teak Research Consults - Dunwoody, Dunwoody
- Teak Research Consults, Lawrenceville
- Clinical Research Atlanta, Stockbridge
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Canton
- AURORA-2 Clinical Site, Decatur
- AURORA-2 Clinical Site, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Canton
- AURORA-1 Clinical Site, Decatur
- AURORA-1 Clinical Site, Union City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Decatur
RecruitingPhase 1/2Healthy volunteers welcome
Ages 25 to 75 · All sexes · Updated Sep 14, 2026 · NCT07815678AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Conquest Research, Atlanta
- Physicians Research Associates, Lawrenceville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07571005Intermittent Cottonseed Oil Consumption
- University of Georgia, Athens
RecruitingHealthy volunteers welcome
Ages 25 to 75 · All sexes · Updated Sep 9, 2026 · NCT07246408Cottonseed Oil Versus Matched PUFA Effects
- University of Georgia, Athens
RecruitingHealthy volunteers welcome
Ages 25 to 75 · All sexes · Updated Sep 9, 2026 · NCT06382298A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Hope Clin Res & Wellness, Conyers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07745504Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Healthcare of Atlanta at Egleston, Atlanta
RecruitingPhase 2
Ages 7 to 25 · All sexes · Updated Aug 19, 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- American Clinical Trials, LLC, Acworth
- Atlanta Center for Clinical Research_Atlanta, Atlanta
- East Atlanta Cardiology, Conyers
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.